Fund Name | Location |
Beijing Galaxy Star Cultural | Beijing, China, Haidian |
Cambrian Biopharma | New York, New York, United States |
Cosun Venture Capital | - |
CPC & Partners | Canada, Ontario, Toronto |
Fujian Huamin Industry Group | China, Foochow, Fujian |
HDG Inc | Canada, Quebec, Quebec |
Kateeva | California, Newark, United States |
Miramar Ventures | California, Corona Del Mar, United States |
Nanyang Ventures | Australia, New South Wales, Sydney |
Neev Fund | India, Maharashtra, Mumbai |
PAYFAZZ | Indonesia, Jakarta, Jakarta Raya |
Ridgeline Ventures | Boulder, Colorado, United States |
Roc Partners | Australia, New South Wales, Sydney |
Rosebud Fund | - |
Success Group | China, Foshan, Guangdong |
The Melohn Group | - |
University of Pittsburgh Innovation Institute | Pennsylvania, Pittsburgh, United States |
Unocal Corporation | California, San Ramon, United States |
Xinghao Venture Management Center | - |
Xinyuan Investment | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.